Seed Funds for Visionary Programs
As a partner who shares Children’s Hospital of Philadelphia’s bold vision for pediatric care, the Chappell Culpeper Family Foundation invests in programs that have the potential not only to save lives today but to change the future trajectory of medicine.
With John Chappell as the founder and daughter Jennifer Paradis Behle as the CEO, the foundation provided funding in 2016 to help catapult the launch of CHOP’s first Frontier Program for Lymphatic Imaging and Interventions, now named the Jill and Mark Fishman Center for Lymphatic Disorders. The team, led by Yoav Dori, MD, PhD, has been a pioneer in mapping the anatomy and flow of the oncemysterious lymphatic system. They’ve developed novel advanced imaging and interventional techniques to diagnose and treat life-threatening lymphatic system disorders. Because lymph is everywhere in the body, these discoveries are profound and broad reaching. Patients from around the world now travel to CHOP in search of care for these often undiagnosed and difficult-to-treat conditions.
Recognizing the widespread impact that seed funding has had in the ongoing success story of lymphatics, the Chappell Culpeper Family Foundation recently committed to supporting two additional cutting-edge programs at CHOP.
The first aims to cure congenital diseases before birth, providing parents a chance to deliver healthier babies. William Peranteau, MD, who holds the Adzick-McCausland Distinguished Chair in Fetal and Pediatric Surgery, leads this innovative endeavor, which uses prenatal gene editing to cure devastating and sometimes lethal disorders that otherwise lack viable treatment options. The second program is poised to improve how children recover from lifethreatening injuries. Led by Todd Kilbaugh, MD, this team works to develop new technologies to transform medical care for children who may experience a range of trauma, such as traumatic brain injury, cardiac arrest, chemical weapons exposure and conditions that require extracorporeal life support.
The foundation has also pledged strategic support for CHOP’s new hospital in King of Prussia, which will open in fall 2021 and will give a wide arc of communities — from Princeton to the east to Lancaster to the west — easier access to a 24-hour Emergency Department and CHOP’s world-class specialists, including those from Oncology and Orthopaedics, both ranked #1 in the nation for pediatric specialties by U.S. News & World Report. As the Chair of the King of Prussia Hospital Campaign, Ms. Paradis Behle is helping to lead the effort to raise philanthropic dollars.
Seed Funds for Visionary Programs
As a partner who shares Children’s Hospital of Philadelphia’s bold vision for pediatric care, the Chappell Culpeper Family Foundation invests in programs that have the potential not only to save lives today but to change the future trajectory of medicine.
With John Chappell as the founder and daughter Jennifer Paradis Behle as the CEO, the foundation provided funding in 2016 to help catapult the launch of CHOP’s first Frontier Program for Lymphatic Imaging and Interventions, now named the Jill and Mark Fishman Center for Lymphatic Disorders. The team, led by Yoav Dori, MD, PhD, has been a pioneer in mapping the anatomy and flow of the oncemysterious lymphatic system. They’ve developed novel advanced imaging and interventional techniques to diagnose and treat life-threatening lymphatic system disorders. Because lymph is everywhere in the body, these discoveries are profound and broad reaching. Patients from around the world now travel to CHOP in search of care for these often undiagnosed and difficult-to-treat conditions.
Recognizing the widespread impact that seed funding has had in the ongoing success story of lymphatics, the Chappell Culpeper Family Foundation recently committed to supporting two additional cutting-edge programs at CHOP.
The first aims to cure congenital diseases before birth, providing parents a chance to deliver healthier babies. William Peranteau, MD, who holds the Adzick-McCausland Distinguished Chair in Fetal and Pediatric Surgery, leads this innovative endeavor, which uses prenatal gene editing to cure devastating and sometimes lethal disorders that otherwise lack viable treatment options. The second program is poised to improve how children recover from lifethreatening injuries. Led by Todd Kilbaugh, MD, this team works to develop new technologies to transform medical care for children who may experience a range of trauma, such as traumatic brain injury, cardiac arrest, chemical weapons exposure and conditions that require extracorporeal life support.
The foundation has also pledged strategic support for CHOP’s new hospital in King of Prussia, which will open in fall 2021 and will give a wide arc of communities — from Princeton to the east to Lancaster to the west — easier access to a 24-hour Emergency Department and CHOP’s world-class specialists, including those from Oncology and Orthopaedics, both ranked #1 in the nation for pediatric specialties by U.S. News & World Report. As the Chair of the King of Prussia Hospital Campaign, Ms. Paradis Behle is helping to lead the effort to raise philanthropic dollars.